Characterization of cellular senescence mechanisms in human corneal endothelial cells

Aging Cell

Volumn 11, Issue 2, 2012, Pages 234-240

  Sheerin, Angela N ^a   Smith, S Kaye ^b   Jennert Burston, Katrin ^a   Brook, Amy J ^b   Allen, Marcus C ^a   Ibrahim, Badr ^a   Jones, Dawn ^a   Wallis, Corrin ^a   Engelmann, Katrin ^c,d   Rhys Williams, William ^e   Faragher, Richard G A ^a   Kipling, David ^b  

^a UNIVERSITY OF BRIGHTON   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c KLINIKUM CHEMNITZ   (Germany)

^d CENTER FOR REGENERATIVE THERAPIES DRESDEN   (Germany)

^e Destiny Pharma Ltd   (United Kingdom)

Author keywords

CDK4; Oxidative stress; P53; Replicative senescence; Senescence; Telomerase; Telomeres

Indexed keywords

CYCLIN DEPENDENT KINASE 4; POTASSIUM CHANNEL; PROTEIN P53; TELOMERASE REVERSE TRANSCRIPTASE;

ARTICLE; CELL AGING; CELL DEDIFFERENTIATION; CELL IMMORTALIZATION; CELL PROLIFERATION; CELL SURVIVAL; CORNEA ENDOTHELIUM; GENE SILENCING; HUMAN; HUMAN CELL; OXYGEN CONCENTRATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TEMPERATURE SENSITIVITY;

CELL AGING; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE 4; ENDOTHELIAL CELLS; ENDOTHELIUM, CORNEAL; HUMANS; OXIDATIVE STRESS; TRANSCRIPTOME; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84858337969     PISSN: 14749718     EISSN: 14749726     Source Type: Journal    
DOI: 10.1111/j.1474-9726.2011.00776.x     Document Type: Article

References (38)

1. Adams PD (2009) Healing and hurting: molecular mechanisms, functions, and pathologies of cellular senescence. Mol. Cell 36, 2-14.
2. Ahmed S, Passos JF, Birket MJ, Beckmann T, Brings S, Peters H, Birch-Machin MA, von Zglinicki T, Saretzki G (2008) Telomerase does not counteract telomere shortening but protects mitochondrial function under oxidative stress. J. Cell Sci. 121, 1046-1053.
3. d'Adda di Fagagna F, Reaper PM, Clay-Farrace L, Fiegler H, Carr P, Von Zglinicki T, Saretzki G, Carter NP, Jackson SP (2003) A DNA damage checkpoint response in telomere-initiated senescence. Nature 426, 194-198.
4. Blais A, Dynlacht BD (2004) Hitting their targets: an emerging picture of E2F and cell cycle control. Curr. Opin. Genet. Dev. 14, 527-532.
5. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB, Shay JW, Lichtsteiner S, Wright WE (1998) Extension of life-span by introduction of telomerase into normal human cells. Science 279, 349-352.
6. Bonanno JA (2011) Molecular mechanisms underlying the corneal endothelial pump. Exp. Eye Res. doi:.
7. Bond JA, Haughton MF, Rowson JM, Smith PJ, Gire V, Wynford-Thomas D, Wyllie FS (1999) Control of replicative life span in human cells: barriers to clonal expansion intermediate between M1 senescence and M2 crisis. Mol. Cell. Biol. 19, 3103-3114.
8. Campisi J, d'Adda di Fagagna F (2007) Cellular senescence: when bad things happen to good cells. Nat. Rev. Mol. Cell Biol. 8, 729-740.
9. Chong EM, Dana MR (2008) Graft failure IV. Immunologic mechanisms of corneal transplant rejection. Int. Ophthalmol. 28, 209-222.
10. Davis T, Singhrao SK, Wyllie FS, Haughton MF, Smith PJ, Wiltshire M, Wynford-Thomas D, Jones CJ, Faragher RG, Kipling D (2003) Telomere-based proliferative lifespan barriers in Werner-syndrome fibroblasts involve both p53-dependent and p53-independent mechanisms. J. Cell Sci. 116, 1349-1357.
11. Engelmann K, Bohnke M, Friedl P (1988) Isolation and long-term cultivation of human corneal endothelial cells. Invest. Ophthalmol. Vis. Sci. 29, 1656-1662.
12. Engelmann K, Bednarz J, Valtink M (2004) Prospects for endothelial transplantation. Exp. Eye Res. 78, 573-578.
13. Engler C, Kelliher C, Wahlin KJ, Speck CL, Jun AS (2009) Comparison of non-viral methods to genetically modify and enrich populations of primary human corneal endothelial cells. Mol. Vis. 15, 629-637.
14. Enomoto K, Mimura T, Harris DL, Joyce NC (2006) Age differences in cyclin-dependent kinase inhibitor expression and rb hyperphosphorylation in human corneal endothelial cells. Invest. Ophthalmol. Vis. Sci. 47, 4330-4340.
15. Evans RJ, Wyllie FS, Wynford-Thomas D, Kipling D, Jones CJ (2003) A P53-dependent, telomere-independent proliferative life span barrier in human astrocytes consistent with the molecular genetics of glioma development. Cancer Res. 63, 4854-4861.
16. Faragher RG, Hardy SP, Davis T, Dropcova S, Allen MC (1997a) Cycling Werner's syndrome fibroblasts display calcium-dependent potassium currents. Exp. Cell Res. 231, 119-122.
17. Faragher RG, Mulholland B, Tuft SJ, Sandeman S, Khaw PT (1997b) Aging and the cornea. Br. J. Ophthalmol. 81, 814-817.
18. Fischbarg J, Maurice DM (2004) An update on corneal hydration control. Exp. Eye Res. 78, 537-541.
19. Joyce NC (2003) Proliferative capacity of the corneal endothelium. Prog. Retin Eye Res. 22, 359-389.
20. Joyce NC, Harris DL, Zhu CC (2011) Age-related gene response of human corneal endothelium to oxidative stress and DNA damage. Invest. Ophthalmol. Vis. Sci. 52, 1641-1649.
21. Kipling D, Jones DL, Smith SK, Giles PJ, Jennert-Burston K, Ibrahim B, Sheerin AN, Evans AJ, Rhys-Willams W, Faragher RG (2009) A transcriptomic analysis of the EK1.Br strain of human fibroblastoid keratocytes: the effects of growth, quiescence and senescence. Exp. Eye Res. 88, 277-285.
22. Kiyono T, Foster SA, Koop JI, McDougall JK, Galloway DA, Klingelhutz AJ (1998) Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 396, 84-88.
23. Klenkler B, Sheardown H (2004) Growth factors in the anterior segment: role in tissue maintenance, wound healing and ocular pathology. Exp. Eye Res. 79, 677-688.
24. Konomi K, Joyce NC (2007) Age and topographical comparison of telomere lengths in human corneal endothelial cells. Mol. Vis. 13, 1251-1258.
25. Lee MS, Yaar M, Eller MS, Rünger TM, Gao Y, Gilchrest BA (2009) Telomeric DNA induces p53-dependent reactive oxygen species and protects against oxidative damage. J. Dermatol. Sci. 56, 154-162.
26. Lian XJ, Gallouzi IE (2009) Oxidative stress increases the number of stress granules in senescent cells and triggers a rapid decrease in p21waf1/cip1 translation. J. Biol. Chem. 284, 8877-8887.
27. Mimura T, Joyce NC (2006) Replication competence and senescence in central and peripheral human corneal endothelium. Invest. Ophthalmol. Vis. Sci. 47, 1387-1396.
28. Passos JF, Nelson G, Wang C, Richter T, Simillion C, Proctor CJ, Miwa S, Olijslagers S, Hallinan J, Wipat A, Saretzki G, Rudolph KL, Kirkwood TB, von Zglinicki T (2010) Feedback between p21 and reactive oxygen production is necessary for cell senescence. Mol. Syst. Biol. 6, 347.
29. Rae JL, Watsky MA (1996) Ionic channels in corneal endothelium. Am. J. Physiol. 270, C975-C989.
30. Reichl S, Bednarz J, Muller-Goymann CC (2004) Human corneal equivalent as cell culture model for in vitro drug permeation studies. Br. J. Ophthalmol. 88, 560-565.
31. Robertson DM, Li L, Fisher S, Pearce VP, Shay JW, Wright WE, Cavanagh HD, Jester JV (2005) Characterization of growth and differentiation in a telomerase-immortalized human corneal epithelial cell line. Invest. Ophthalmol. Vis. Sci. 46, 470-478.
32. Ruas M, Gregory F, Jones R, Poolman R, Starborg M, Rowe J, Brookes S, Peters G (2007) CDK4 and CDK6 delay senescence by kinase-dependent and p16INK4a-independent mechanisms. Mol. Cell. Biol. 27, 4273-4282.
33. Shay JW, Wright WE (2005) Use of telomerase to create bioengineered tissues. Ann. N Y Acad. Sci. 1057, 479-491.
34. Song Z, Wang Y, Xie L, Zang X, Yin H (2008) Expression of senescence-related genes in human corneal endothelial cells. Mol. Vis. 14, 161-170.
35. Vaziri H, Benchimol S (1998) Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr. Biol. 8, 279-282.
36. Webley K, Bond JA, Jones CJ, Blaydes JP, Craig A, Hupp T, Wynford-Thomas D (2000) Posttranslational modifications of p53 in replicative senescence overlapping but distinct from those induced by DNA damage. Mol. Cell. Biol. 20, 2803-2808.
37. Zhu C, Joyce NC (2004) Proliferative response of corneal endothelial cells from young and older donors. Invest. Ophthalmol. Vis. Sci. 45, 1743-1751.
38. Zhu CH, Mouly V, Cooper RN, Mamchaoui K, Bigot A, Shay JW, Di Santo JP, Butler-Browne GS, Wright WE (2007) Cellular senescence in human myoblasts is overcome by human telomerase reverse transcriptase and cyclin-dependent kinase 4: consequences in aging muscle and therapeutic strategies for muscular dystrophies. Aging Cell. 6, 515-523.